Patent · US Active

Diagnostics for membranous nephropathy

US8507215B2 · kind B2 · utility

2Cited by

1References

20Claims

0Family size

Assignees

BOSTON MEDICAL CENTER CORPORATION · US
LE CENTRE NATIONAL DE LARECHERCHE SCIENTIFIQUE · FR

Inventors

David J. Salant · Newton, US
Laurence H. Beck · Kingston, US
Gerard Lambeau · Grasse, FR

Key dates

Filing date	Jan 14, 2011
Grant date	Aug 13, 2013
Priority date	—
Expiry date	Jan 14, 2031

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/918
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention provides immunoassays for detecting serum auto-antibodies reactive against a phospholipase A2 receptor (PLA2R) and uses thereof for diagnosis and prognosis evaluation of idiopathic membranous nephropathy (MN).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.